Musk v. Altman: Inside the OpenAI Trial Repricing AI

At 10:13 a.m. Eastern on Friday, May 8, 2026, the stock market was open and the OpenAI trial had moved from spectacle into price discovery. Nvidia was trading near $216, Microsoft near $417 and Tesla near $427 in live snapshots captured by TECHi's market data stack. Bitcoin was near $79,882, a useful risk-appetite check because AI infrastructure, crypto liquidity and high-beta technology stocks have been trading as one broad capital-duration complex in 2026.

The courtroom story is easy to overstate and easy to miss. Elon Musk is not asking a jury to decide whether artificial intelligence will save or destroy humanity. The April 17 pretrial order says the case is being split into a liability phase before an advisory jury and a remedies phase before Judge Yvonne Gonzalez Rogers, with the remedies phase likely to begin May 18 if the case gets that far. That makes the trial a governance test for the most valuable private AI company in the world, not just another founder feud.

For TECHi readers, the sharper question is whether OpenAI's nonprofit-to-public-benefit-corporation structure becomes a validated capital-market template or a cautionary precedent for mission-driven AI companies that need trillions of dollars of compute. That is why this case belongs next to TECHi's OpenAI IPO framework, its Microsoft and OpenAI capital stack analysis and the newer Nvidia-OpenAI infrastructure thesis.

Background: the charity claim meets the capital machine

OpenAI began in 2015 as a nonprofit, and the company's current structure page says the for-profit arm is OpenAI Group PBC, with the OpenAI Foundation holding 26% and Microsoft holding roughly 27% after the recapitalization. The court's case page summarizes Musk's complaint as alleging that Altman, Greg Brockman and OpenAI-related entities induced him to help found and fund a nonprofit devoted to safe AI, then shifted toward a profit-driven structure that allegedly concentrated benefits with Microsoft and for-profit affiliates.

Musk's side frames the dispute in blunt charitable-trust language. His amended notice of remedies says he is not seeking damages for himself personally and instead wants alleged ill-gotten gains returned to the OpenAI charity, while also seeking to strip Altman and Brockman of authority and unwind the for-profit conversion. OpenAI counters that the written record tells a different story: in its public response, the company says Musk agreed in 2017 that a for-profit structure would be the next phase, demanded full control, later pushed a Tesla merger path, and then left.

That defense matters because it moves the trial from origin myth to governance paper trail. A founder's early mission language can be powerful, but investors price documents, cap tables and enforceable rights. If Gonzalez Rogers ultimately accepts OpenAI's view, the company gains a legal validation layer for its PBC structure. If she accepts even part of Musk's theory, every late-stage AI company with a public-benefit wrapper will face a new diligence checklist.

The trial so far: drama, discipline and a judge narrowing the frame

The court opened public audio access on May 4 and said the livestream would generally run while court is in session through roughly May 21. That schedule matters because the market has not yet seen the full witness slate. Musk has testified. Brockman has testified. Murati has appeared by video. Zilis has testified. Satya Nadella, Ilya Sutskever and Altman remain central to the expected arc.

Musk's testimony gave the media the line it wanted: he repeated that one cannot steal a charity. The Guardian reported that Gonzalez Rogers struck one repetition from the record, saying the court had heard it many times, and later cut off broader extinction talk by telling the lawyers that the trial would not spend much time on that issue. The Washington Post reported another judicial rebuke after Musk accused OpenAI's lawyer William Savitt of asking a leading question, with the judge prompting Musk to say, "I'm not a lawyer."

The most important moment for investors may have been less theatrical. Reuters reported through Investing.com that Brockman disclosed an OpenAI stake worth nearly $30 billion, said he had not personally invested money in OpenAI, and described additional financial ties to Altman-backed vehicles. Musk's lawyers will use that testimony to argue enrichment and independence problems. OpenAI will argue that high equity value is the predictable result of building a world-scale company, not proof that a charity was looted.

Murati's testimony added a second governance layer. Reuters separately reported that the former CTO said Altman pitted executives against one another and that OpenAI was at catastrophic risk of falling apart during the 2023 board crisis, while also saying she wanted Altman to remain CEO and wanted clearer justification from the board. Zilis's testimony added a third layer: The Guardian reported that she said OpenAI's early years included many ideas about structure, including a for-profit branch, and that she initially agreed billion-dollar Microsoft investments could help fulfill OpenAI's mission.

Then there is the xAI angle. TechCrunch reported that Musk acknowledged xAI had used distillation techniques involving OpenAI models, while describing distillation as a broader industry practice. That is not the legal center of the case, but it is strategic context. Musk is suing as a former founder and donor; he is also the owner of a direct AI competitor. OpenAI's theory that the lawsuit is competitive sabotage becomes easier to explain when xAI is in the background.

The legal battlefield: liability first, remedies later

The judge's order is the cleanest guide to the case. It gives Musk and the OpenAI defendants 22 hours each for the liability phase, gives Microsoft five hours, bars remedy details during the liability phase, and states that the advisory jury will hear liability while the court will hear remedies. It also notes the court has reservations about Musk's request to direct disgorgement to the nonprofit and ordered a verified waiver if Musk continues down that route.

Musk's remaining case is best understood as a package of charitable-trust and unjust-enrichment theories, with fraud-related claims constrained by prior rulings and procedural orders. He wants structural relief, not just money. That could include leadership removal, restrictions on how the PBC operates, disgorgement directed to the charity, and some form of unwinding or limitation on the for-profit structure.

OpenAI's defense is equally clear. It says Musk knew the nonprofit model could not fund frontier-scale compute, supported a for-profit transition when it suited him, tried to obtain control, left in 2018, and now wants courts to slow a competitor. That argument does not require jurors to love Altman. It only requires the judge to find that Musk lacks an enforceable promise broad enough to reverse a company that has since taken hundreds of billions of dollars in capital commitments.

The distinction is crucial. A jury can dislike self-enrichment and still leave the judge with narrow remedies. A judge can find Musk's motive mixed and still find enforceable charitable obligations. The case is not binary in the way social media presents it.

If Musk wins: OpenAI's IPO path gets a legal overhang

A full Musk win would be the most severe outcome. It could force OpenAI closer to nonprofit control, impose tighter public-benefit constraints, require disgorgement, or remove Altman and Brockman from authority. Even a partial win could slow an IPO timeline because public-market investors would need audited clarity on governance, related-party economics, Microsoft rights, employee equity, foundation control and remedy exposure.

That is a real valuation issue. OpenAI announced in February that it had raised $110 billion at a $730 billion pre-money valuation, including $30 billion each from Nvidia and SoftBank and $50 billion from Amazon. The same announcement said the foundation stake was worth more than $180 billion after the round and described new Nvidia capacity that includes 3 GW of inference and 2 GW of training on Vera Rubin systems. If a court adds uncertainty to that structure, the impact extends beyond OpenAI's private cap table.

Microsoft is the first public-market read-through. The October partnership update said Microsoft's OpenAI stake was valued at about $135 billion and that OpenAI had contracted to buy an incremental $250 billion of Azure services. If remedies restrict OpenAI's commercial operations, Microsoft would not lose Copilot overnight, but investors would revisit the duration and exclusivity assumptions behind its AI stack.

Nvidia is the second. MarketBeat showed Nvidia at $216.28 shortly after 10 a.m. Eastern on May 8, with a $275.25 average analyst target across 54 ratings. That consensus reflects durable AI demand, but the trial introduces a different risk: not whether GPUs are useful, but whether the largest AI buyers can keep financing, governing and deploying infrastructure at the speed that current targets imply. TECHi has covered this supplier feedback loop in its Nvidia and OpenAI megadeal analysis.

Musk's own competitive upside would be harder to quantify but real. A court-imposed leadership or structure shock at OpenAI would give xAI a narrative opening with enterprise buyers, talent and capital providers. It would also let Musk argue that OpenAI's scale was built on a disputed governance foundation, even if the legal remedy falls short of a full unwind.

If OpenAI wins: the PBC model gets a market green light

An OpenAI win would not erase reputational bruising from the testimony. It would, however, validate the architecture investors care about: nonprofit control, a PBC operating company, a massive foundation stake, Microsoft economics, outside strategic investors and enough flexibility to buy compute from multiple cloud and chip partners.

That outcome would likely help OpenAI's IPO optionality. Axios reported at trial start that OpenAI was targeting a fourth-quarter IPO at a reported $852 billion valuation. A clean win would not guarantee that number, but it would remove a legal discount at the exact moment OpenAI is trying to convert product scale into a public-market story.

It would also send a broader industry signal: founder promises have limits when they are not converted into enforceable restrictions. That may sound harsh, but capital markets generally prefer that answer. Frontier AI companies are not ordinary software startups. Their funding needs resemble national infrastructure programs. Investors will back mission language, but they will discount ambiguity around who controls assets after the money is committed.

The Microsoft-OpenAI April 2026 amendment points in the same direction. Microsoft said it remains OpenAI's primary cloud partner, OpenAI products ship first on Azure unless Microsoft cannot or chooses not to support the necessary capabilities, and Microsoft's OpenAI IP license now runs through 2032 on a non-exclusive basis. In other words, the partnership is becoming less exclusive but more explicit. A defense win would make that evolution easier to underwrite.

The market fallout: AI governance becomes a valuation input

This trial should change how investors talk about AI moats. Model quality still matters. Distribution still matters. Data-center access still matters. But governance is now a financial variable, not a footnote.

For Microsoft, the question is whether OpenAI remains a scalable strategic asset or becomes a litigation-constrained partner with limits on capital raises and commercialization. For Nvidia, the question is whether the biggest model labs can keep using future equity value to fund future compute purchases. For Tesla, the trial is less about direct earnings and more about Musk's credibility as the builder of xAI and as the public narrator of AI risk.

For private AI investors, the lesson is immediate. A public-benefit corporation cannot be sold as a magic bridge between charity and profit unless the documents clearly define who controls the mission, who benefits economically and what happens when capital needs overwhelm original governance assumptions. The next OpenAI-style fundraising will face tougher questions on founder rights, nonprofit consent, related-party dealings, board independence and exit mechanics.

There is also a policy dimension. TECHi's earlier coverage of OpenAI asking attorneys general to examine Musk's conduct showed how quickly corporate litigation can become regulatory theater. If Gonzalez Rogers finds a meaningful breach, state charity regulators and attorneys general will have a fresh template. If she does not, AI companies will argue that PBC structures can preserve mission while allowing scale.

What investors should watch next

The next phase is not about who produces the best sound bite. Watch four things.

First, whether Nadella's testimony reinforces Microsoft's position as a commercial partner rather than a controller. Second, whether Sutskever's testimony supports Musk's origin story or OpenAI's capital-necessity defense. Third, whether Altman can answer governance and conflict questions without turning the case back into personality. Fourth, whether the advisory jury gives Gonzalez Rogers a liability finding that is narrow enough to avoid structural remedies.

The stock-market reaction may stay muted until remedies become plausible. That does not make the case unimportant. It means the risk is contingent. OpenAI is private, so the public-market expression is indirect: MSFT for partnership economics, NVDA for AI infrastructure demand, TSLA for Musk/xAI narrative, and broader high-beta tech for risk appetite.

The more precise investor view is this: OpenAI's valuation is not being tried in court, but the assumptions underneath that valuation are. Can a mission-first entity become a capital-intensive AI platform without losing its legal soul? Can a founder-donor enforce old promises after leaving and launching a rival? Can a judge craft remedies that protect charitable commitments without detonating a company that now sits at the center of the AI economy?

Those questions will echo beyond Oakland. The AI industry is watching because the verdict, expected in mid-to-late May 2026 if the current schedule holds, could define how the next trillion dollars of frontier AI capital is structured.